UK Medical Polyoxymethylene (pom) Market Size & Outlook
Related Markets
UK medical polyoxymethylene (pom) market highlights
- The UK medical polyoxymethylene (pom) market generated a revenue of USD 47.6 million in 2025 and is expected to reach USD 84.6 million by 2033.
- The UK market is expected to grow at a CAGR of 7.8% from 2026 to 2033.
- In terms of segment, copolymer pom was the largest revenue generating type in 2025.
- Copolymer POM is the most lucrative type segment registering the fastest growth during the forecast period.
Medical polyoxymethylene (pom) market data book summary
| Market revenue in 2025 | USD 47.6 million |
| Market revenue in 2033 | USD 84.6 million |
| Growth rate | 7.8% (CAGR from 2026 to 2033) |
| Largest segment | Copolymer pom |
| Fastest growing segment | Copolymer POM |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Homopolymer POM, Copolymer POM |
| Key market players worldwide | Dow Inc, Celanese Corp Class A, DuPont de Nemours Inc, Daicel Corp, Asahi Kasei Corp, Mitsubishi Gas Chemical Co Inc, SABIC, Avient Corp, Clariant AG, Jet-Hot, Innovative Plastics, Korea Engineering Plastics Co., China National Bluestar Group, ICD High Performance Coatings |
Other key industry trends
- In terms of revenue, UK accounted for 3.6% of the global medical polyoxymethylene (pom) market in 2025.
- Country-wise, China is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany medical polyoxymethylene (pom) market is projected to lead the regional market in terms of revenue in 2033.
- Norway is the fastest growing regional market in Europe and is projected to reach USD 33.0 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Medical Polyoxymethylene (POM) Market Scope
Medical Polyoxymethylene (POM) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| ICD High Performance Coatings | View profile | 11-50 | Ridgefield, Washington, United States, North America | https://www.icdcoatings.com/ |
| China National Bluestar Group | View profile | 10001+ | Beijing, Beijing, China, Asia | http://www.china-bluestar.com/ |
| Korea Engineering Plastics Co. | View profile | 101-250 | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | https://www.kepital.com |
| Innovative Plastics | View profile | 101-250 | Orangeburg, New York, United States, North America | https://www.innovative-plastics.com/ |
| Jet-Hot | View profile | 11-50 | Burlington, North Carolina, United States, North America | https://www.jet-hot.com |
| SABIC | View profile | 10001+ | Riyadh, Ar Riyad, Saudi Arabia, Asia | http://www.sabic.com |
| Daicel Corp | View profile | 12480 | Grand Front Osaka Tower-B, 3-1, Ofuka-cho, Kita-ku, Osaka, Japan | http://www.daicel.com |
| Clariant AG | View profile | 10481 | Rothausstrasse 61, Muttenz, Switzerland, 4132 | http://www.clariant.com |
| Mitsubishi Gas Chemical Co Inc | View profile | 10050 | 5-2 Marunouchi 2-chome, Chiyoda-ku, Tokyo, Japan, 100-8324 | http://www.mgc.co.jp |
| Celanese Corp Class A | View profile | 12410 | 222 West Las Colinas Boulevard, Suite 900N, Irving, TX, United States, 75039-5421 | https://www.celanese.com |
| DuPont de Nemours Inc | View profile | 24000 | 974 Centre Road, Building 730, Wilmington, DE, United States, 19805 | https://www.dupont.com |
| Avient Corp | View profile | 9300 | 33587 Walker Road, Avon Lake, OH, United States, 44012 | https://www.avient.com |
| Asahi Kasei Corp | View profile | 48897 | 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo, Japan, 101-8101 | http://www.asahi-kasei.co.jp |
| Dow Inc | View profile | 35900 | 2211 H.H. Dow Way, Midland, MI, United States, 48674 | https://www.dow.com |
UK medical polyoxymethylene (pom) market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical polyoxymethylene (pom) market will help companies and investors design strategic landscapes.
Copolymer pom was the largest segment with a revenue share of 66.18% in 2025. Horizon Databook has segmented the UK medical polyoxymethylene (pom) market based on homopolymer pom, copolymer pom covering the revenue growth of each sub-segment from 2021 to 2033.
The UK is an important country in the global medical POM market due to its ageing population and extensive healthcare system. The publicly funded National Health Service (NHS) accounts for 86% of the UK government’s healthcare provisions, spending approximately USD 13 billion per year on medical technology.
The UK government published an official MedTech strategy in February 2023, for the promotion of effective and innovative technologies in the country in collaboration with NHS, acting as a driver for the medical POM market.
Reasons to subscribe to UK medical polyoxymethylene (pom) market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK medical polyoxymethylene (pom) market databook
-
Our clientele includes a mix of medical polyoxymethylene (pom) market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK medical polyoxymethylene (pom) market , including forecasts for subscribers. This country databook contains high-level insights into UK medical polyoxymethylene (pom) market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
UK medical polyoxymethylene (pom) market size, by type, 2021-2033 (US$M)
UK Medical Polyoxymethylene (POM) Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
